Table 2.

Description of the treatment in the included studies

Study	Model*	Treatment duration (months)	Drugs in regimen †	DOTS location	DOTS provider	Additional community involvement
Drobac et al. [19]	I	18-24	n/a	Local health centre	CHWs, nurses	CHWs provided doses outside centre hours
Joseph et al. [17]	S	6-9, 18	6,4	Local health centre	HCWs, friends/neighbours	Health education provided for family
Malla et al. [22]	S	8-12,16-24	5,4	Decentralized clinics	Health workers	Nominated treatment support person required
Mitnick et al. [20]	I	Median 23 (0 · 4-35 · 9)	Median 6 (5-9)	Outpatient	CHWs, nurses	-
Mitnick et al. [21]	I	≥18	≥5	Health centre or patient home	CHWs	Group therapy as needed
Oyieng’o et al. [24]	S	≥6, 18	5,4	Local health centre or patient home	Local nurse, HCW, household member	Household member supervised evening dose
Satti et al. [25]	I	≥18	6	Outpatient	CHWs	Community team tracked patients and provided support
Singla et al. [16]	S	6-9, 18	5,3	Peripheral health centre or patient home	HCW, household member	Household member supervised evening dose
Thomas et al. [18]	I	≥18	5, ≥2	Village health centres, clinics or hospital	Anganwadi workers, village HCWs, private practitioners	-
Tupasi et al. [26]	I	≥6, ≥18	5, 4	Local health centre, or patient home	HCWs	Treatment partner nominated by the patient

*I = Individualized, S = Standardized.

^‡Duration of intensive phase and continuation phase are separated by a comma. Otherwise duration represents length of treatment. ^†Number of drugs in intensive and continuation regimens separated by a comma.